IT vs TENX · P/E 16, rev $6.27B vs P/E 3.4, $24.1M cap
Gartner Inc (IT) versus Tenax Therapeutics Inc (TENX) — a side-by-side from cached financials, not a winner call.
Gartner Inc (IT) is a information technology services company listed on US.
Tenax Therapeutics Inc (TENX) is a biotechnology company listed on US.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Latest reported TENX revenue for 2025-09-30 was $0. Net income was -$37.1M. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
IT currently screens at market cap $11.03B and trailing P/E 16.3. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
Not investment advice. Open the IT and TENX stock pages for the full models.
Not investment advice.